What is Semler Scientific?
Semler Scientific, Inc. operates at the intersection of medical technology and clinical efficiency, providing innovative solutions designed to assist healthcare providers in the evaluation and treatment of chronic conditions. The company's flagship product, QuantaFlo, is an FDA-cleared, rapid point-of-care diagnostic tool that measures arterial blood flow to aid in the detection of peripheral arterial disease. By enabling physicians and insurance providers to identify risks for heart attacks and strokes with greater precision, Semler Scientific facilitates more informed patient care pathways. Its business model is built upon the integration of patented diagnostic hardware with data-driven insights, allowing for improved health outcomes and operational efficiency within the broader healthcare ecosystem.
How much funding has Semler Scientific raised?
Semler Scientific has raised a total of $31.5M across 2 funding rounds:
Stock Offering
$10M
Share Placement
$21.5M
Stock Issuance/Offering (2014): $10M, investors not publicly disclosed
Share Placement (2024): $21.5M, investors not publicly disclosed
Key Investors in Semler Scientific
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Semler Scientific?
With the successful completion of this major enterprise-level funding, Semler Scientific is poised to expand its footprint in the diagnostic technology market. The strategic allocation of these funds will likely focus on scaling the distribution of the QuantaFlo platform and potentially diversifying its product pipeline to address a wider array of chronic diseases. As the healthcare industry continues to prioritize preventative care and data-backed clinical decision-making, Semler Scientific is strategically aligned to capture further market share. The company's focus remains on leveraging its FDA-cleared technology to provide actionable intelligence to its insurance and physician partners, thereby reinforcing its role as a critical component of modern, value-based care delivery systems.
See full Semler Scientific company page
